Successfully transplanted a pig’s heart into a man for the first time | Science

It is a milestone for medicine. US surgeons transplanted the heart of a genetically modified pig into a human patient last Friday. David Bennett, 57, had run out of options for a regular transplant due to his conditions, and the University of Maryland Medical Center decided to perform the extraordinary procedure for “compassionate reasons.” Three days after the operation, the recipient is in good condition and under medical surveillance. The operation opens new hope for all patients suffering from the dramatic shortage of human organs available for transplantation.

Bennett knew there was no guarantee that the experimental surgery would work, his son told the Associated Press. “It was either dying or doing this transplant. I wanted to live. I knew there were few possibilities but it was my last option, ”Bennett said the day before the surgery, according to the statement released by the University of Maryland.

Although it is too early to know if the procedure will prolong the life of the patient, it is undoubtedly a huge advance in the long quest to one day be able to transplant organs of animal origin and save human lives. Faculty at the University of Maryland Medical Center noted that the operation demonstrated that the heart of a genetically modified animal can function in the human body without immediate rejection.

The surgery, which lasted eight hours, was successfully performed last Friday at the University of Maryland Medical Center. According to the institution, a pig heart transplant “was the only option available to the patient,” since several hospitals had ruled out the possibility of a conventional transplant.

See also  Student who thought spotty rash was from partying is told it's a side effect of the pill

“If it works, then there will be an inexhaustible supply of these organs for suffering patients,” said Dr. Muhammad Mohiuddin, scientific director of the university’s xenotransplantation (from animals to humans) program. The problem in this type of operation is that the body of the patients quickly rejects the animal organs. One of the best known cases was recorded in 1984, when the baby known as Fae, a dying girl, survived 21 days with the heart of a baboon.

The United States Food and Drug Administration (FDA) authorized the operation of Bennett on New Year’s Eve, who had been bedridden for months and was informed of the risks of the operation, as it was a still experimental technique.

“It has been a revolutionary surgery and brings us one step closer to solving the organ shortage crisis. There are not enough human donor hearts available to meet the long list of potential recipients, ”said Bartley Griffith, doctor in charge of this surgical procedure.

Optimism and caution

Griffith highlighted the importance of the intervention, but also expressed his reservations: “We are proceeding with caution, but we are also optimistic that this first surgery in the world will provide an important new option for patients in the future.”

Bennett’s genetically modified pig heart was provided by Revivicor, a regenerative medicine company based in Blacksburg, Virginia. On the morning of surgery, the transplant team removed the pig’s heart and placed it in a special device to preserve its function until surgery, Reuters reports.

Pigs have long been a potential source of transplants, as their organs are very similar to humans and their size is close to that of an adult human. Other pig organs that are being investigated for transplantation into humans include kidneys, liver and lungs.

See also  Writing off outstanding school dinners debt in North Lanarkshire could help relieve pressure on struggling families

Gene editing

Previous efforts at pig-to-human transplants have failed due to genetic differences that caused rejection of organs or viruses that pose a risk of infection. Scientists have tackled that problem by editing potentially harmful genes. In Bennett’s implanted heart, three genes previously linked to organ rejection were “knocked out” from the donor pig, and six humans, linked to immune acceptance, were inserted into the pig genome. The researchers also deleted a pig gene to prevent pig heart tissue overgrowth. In addition to the genetic changes in the pig heart, Bennett received an experimental anti-rejection drug manufactured by Lexington, Massachusetts-based Kiniksa Pharmaceuticals.

About 110,000 Americans are currently waiting for an organ transplant, and more than 6,000 patients die each year before receiving one, according to official data cited by the university.

Last October, a New York hospital managed to temporarily transplant the kidney of a genetically modified pig into a human body. The kidney functioned properly for 54 hours, the researchers explained. The operation, led by surgeon Robert Montgomery, implanted the pig kidney in the woman’s left thigh, simply to have the organ in view and to be able to easily monitor it. Urine began to flow as soon as human blood flowed through the pig organ.

But the transplant in Baltimore has now taken that experiment to the next level, Dr. Montgomery, who led the previous experiment at New York University Langone Medical Center, told the AP. “This is a truly remarkable advance,” Montgomery, who has lived with a donor heart for three years, said in a statement. “As a heart transplant recipient and suffering from a genetic heart condition, I am extremely excited about this news and the hope it gives to my family and other patients that this advancement will eventually save their lives.”

See also  Teacher, 23, told she was 'weeks from death' before seeking support with anorexia battle

Subscribe here to the newsletter from EL PAÍS América and receive all the informative keys of the current situation of the region

Related Posts

George Holan

George Holan is chief editor at Plainsmen Post and has articles published in many notable publications in the last decade.

Leave a Reply

Your email address will not be published.